PHASEBIO PHARMA - Stock Price History | PHAS
Historical daily share price chart and data for PHASEBIO PHARMA since 2021 adjusted for splits. The latest closing stock price for PHASEBIO PHARMA as of September 24, 2021 is 3.03.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high PHASEBIO PHARMA stock closing price was 14.66 on April 12, 2019.
- The PHASEBIO PHARMA 52-week high stock price is 5.83, which is 92.4% above the current share price.
- The PHASEBIO PHARMA 52-week low stock price is 2.60, which is 14.2% below the current share price.
- The average PHASEBIO PHARMA stock price for the last 52 weeks is 3.58.
|PHASEBIO PHARMA Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
PhaseBio Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary indications. The company's product consists of PB2452, a novel reversal agent for the antiplatelet drug ticagrelor and PB1046, a once-weekly fusion protein for the treatment of pulmonary arterial hypertension, which are in clinical stage. PhaseBio Pharmaceuticals Inc. is based in Malvern, United States.